Author Archives: Warren Woessner

Yu v. Apple – Transubstantiation of a Machine into an Abstract Idea

Every time the courts re-define a mechanical device as an abstract idea, I struggle with the rationale that is applied to evaluate the claimed subject matter for patent eligibility under s. 101. I am not a computer scientist so the … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , | Leave a comment

Important Amendments to Chinese Patent Law

Guest post from Deshan Li, Ph.D., Executive Vice President and Senior Partner at Unitalen Attorneys at Law. On October 17, 2020, the amendments to the Patent Law were adopted by the Congress, which will come into effect as of June … Continue reading

Posted in Int'l Practice and Policy, Uncategorized | Tagged , , | Leave a comment

Biogen v. Serano – When is a Recombinant Polypeptide Novel?

When I posted about this Fed. Cir. decision (Biogen MA v. EMD Serano, Appeal no. 2019-1133 (Fed. Cir., Sept. 28, 2020) on October 12, 2020, I viewed it as a straightforward application of the maxim that an otherwise non-novel product … Continue reading

Posted in Anticipation | Tagged , , , | Leave a comment

Want an Expedited Decision on your Appeal? Use the USPTO’s Fast Track Appeals Pilot Program

Guest post from the USPTO: What is the Fast-Track Appeals Pilot Program? Under the Fast-Track Appeals Pilot Program, appellants can have their ex parte appeals advanced out of turn. Appellants simply file a petition to request fast-track review of their … Continue reading

Posted in PTAB, USPTO Practice and Policy | Tagged , , | Leave a comment